At a glance
ClinicalIndex Comparison RecordPhase 2Completed
Drug / intervention
Ginkgo biloba extractdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ginkgo Biloba Extract and the Insulin Resistance Syndrome
National Center for Complementary and Integrative Health (NCCIH)·interventional·Posted Mar 22, 2002·Updated Aug 18, 2006
In Brief
A Phase 2 clinical trial evaluating Ginkgo biloba extract for Type 2 Diabetes Mellitus. Completed, across 1 site.
Detailed Summary
The purpose of this study is to examine whether the ingestion of the herbal dietary supplement Ginkgo biloba extract has any effect on the efficacy of three classes of diabetic medications - (Glucotrol, Glucophage and Actose). Additionally, the study will examine the effect of Ginkgo biloba extract on pancreatic insulin production in non-diabetic subjects between the ages of 20 and 75 years old.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2001
First PostedMar 2002
Study CompletionMay 2005
TodayJul 2026
First PostedMar 22, 2002
Enrollment StartDec 1, 2001
Study CompletionMay 1, 2005
TodayJul 2, 2026
Posted 24.3 years ago
Interventions
Ginkgo biloba extractdrug